CAR-T is a powerful tool which is still evolving. Here we highlight what is new in CAR-T cell therapy. Cancer cells often play hide-and-seek with the immune system in an attempt to evade catastrophic ...

In a world first, the NHS has announced it is rolling out ‘blood-test first’ testing for patients with non-small cell lung cancer (NSCLC) in England. The tests have been added to the Genomic Test ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel?. The Regulation amounts to an ambitious and laudable step ...

Professor James Flanagan, Imperial College, London, on the CLOCS project and how data sharing of transactions could speed up cancer diagnosis. The first CLOCS project showed that ovarian cancer ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

We are delighted to confirm formal recognition for our support of the consensus statement on a Roadmap to Global Heat Health Resilience. Organisations across the globe can show also show their support ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

Each year, zettabytes of data are produced globally, which is comparable to the number of stars in the observable universe. This number is increasing at a rapid pace, and in 2025, global yearly data ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

Polygenic scores aim to measure the cumulative effect of multiple genetic variants to make predictions about a person’s health. The most likely areas of potential use are in risk prediction, including ...